Emay Pharmaceuticals Private Limited
About Emay Pharmaceuticals Private Limited
Data last updated:
Emay Pharmaceuticals Private Limited is a private limited company based in Panvel, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 July 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U47721MH2023PTC406480.
The company has an authorised share capital of ₹50,000 and a paid-up capital of ₹50,000. It is led by directors Kinjal Amey Parkar and Amey Parkar Dilip.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Panvel, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹51.41 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹4 Lakh (net margin -7.8%) and EBITDA of -₹2.29 Lakh (EBITDA margin -4.5%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressKohinur Ind Complex, B – 146 Taloja Sec Pnl – 1, Panvel, Maharashtra, India – 410206
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Emay Pharmaceuticals Private Limited
The main business activity of Emay Pharmaceuticals is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Emay Pharmaceuticals Private Limited FY 2025 filings available
Emay Pharmaceuticals Private Limited reported revenue of ₹51.41 Lakh (up 3536% YoY) for FY 2025.
Financial Statement Summary of Emay Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹2.29 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹4 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Emay Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -4.5% | •••• |
| Net Profit Margin | -7.8% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Emay Pharmaceuticals are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Emay Pharmaceuticals Private Limited
Emay Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Axxontis Biopharmaceuticals Private Limited | ₹51.65 Lakh (FY 2024) | •••• | •••• | -1.0% | •••• | Hoshiarpur, Punjab, India |
| Suraj Remedies Private Limited | ₹51.48 Lakh (FY 2025) | •••• | •••• | -54.0% | •••• | Uttar Pradesh, India |
| Belida Pharmaceuticals Private Limited | ₹51.47 Lakh (FY 2025) | •••• | •••• | 73.0% | •••• | Hyderabad, Telangana, India |
| Marigold Pharmaceuticals Private Limited | ₹51.45 Lakh (FY 2025) | •••• | •••• | -40.0% | •••• | Solapur, Maharashtra, India |
| Azorus Healthcare Private Limited | ₹51.44 Lakh (FY 2025) | •••• | •••• | -78.0% | •••• | Mumbai, Maharashtra, India |
| Emay Pharmaceuticals Private Limited this company | ₹51.41 Lakh (FY 2025) | •••• | •••• | 3536.0% | •••• | Panvel, Maharashtra, India |
| Apn Markcon Private Limited | ₹51.4 Lakh (FY 2023) | •••• | •••• | 1198.0% | •••• | Delhi, India |
| Bisam Pharmaceuticals Private Limited | ₹51.39 Lakh (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Jarrot Life Care Private Limited | ₹51.32 Lakh (FY 2024) | •••• | •••• | 15.0% | •••• | Uttar Pradesh, India |
| Eldora Healthcare Private Limited | ₹51.28 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Indore, Madhya Pradesh, India |
| Mdartis Pharmaceuticals Private Limited | ₹51.26 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Emay Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Emay Pharmaceuticals Private Limited
Emay Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kinjal Amey Parkar Also directs: Bhavna Laboratories Pvt Ltd | Director | 12 Jul 2023 | 3 Years 3 Months | Current |
| Amey Parkar Dilip Also directs: Bhavna Laboratories Pvt Ltd | Director | 12 Jul 2023 | 3 Years 3 Months | Current |
Charges & Borrowings of Emay Pharmaceuticals Private Limited
Emay Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Emay Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Emay Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Emay Pharmaceuticals Private Limited
Emay Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Amey Parkar Dilip was appointed as Director on 12 Jul 2023.
Credit Ratings, Litigation & Regulatory Alerts for Emay Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Emay Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Emay Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Emay Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Emay Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emay Pharmaceuticals Private Limited
Emay Pharmaceuticals is an active private limited company based in Panvel, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 July 2023 (3+ years old) and is registered under CIN U47721MH2023PTC406480.
Emay Pharmaceuticals reported revenue of ₹51.41 Lakh for FY 2025 (up 3536% YoY).
Emay Pharmaceuticals has 2 current directors:
- Kinjal Amey Parkar - Director
- Amey Parkar Dilip - Director
Emay Pharmaceuticals reported a net loss of ₹4 Lakh (net margin -7.8%) and EBITDA of -₹2.29 Lakh (EBITDA margin -4.5%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Emay Pharmaceuticals is U47721MH2023PTC406480. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emay Pharmaceuticals was incorporated on 12 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Emay Pharmaceuticals by revenue are Axxontis Biopharmaceuticals Private Limited, Suraj Remedies Private Limited, Belida Pharmaceuticals Private Limited, Marigold Pharmaceuticals Private Limited, Azorus Healthcare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Amey Parkar Dilip was appointed as Director on 12 Jul 2023. Kinjal Amey Parkar was appointed as Director on 12 Jul 2023.
The registered office of Emay Pharmaceuticals is at Kohinur Ind Complex, B – 146 Taloja Sec Pnl – 1, Panvel, Maharashtra, India – 410206.
Emay Pharmaceuticals has an authorised share capital of ₹50,000 and a paid-up capital of ₹50,000.
Emay Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.